Results

Total Results: 2,582 records

Showing results for "testing".

41. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
    June 30, 2015 - Testing in these two situations should be looked at separately. … when compared with no testing. … that no testing for any underlying diagnosis is worthwhile. … They may do focused/targeted aCGH/microarray testing. … Good example of potential risk of testing?

42. Chapter 11: Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests Used as Predictive Indicators | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-genetic/methods
    December 01, 2019 - What are the financial costs associated with testing? … 3b: How well does CYP450 testing predict drug efficacy? … Rather, family history-based testing is the paradigm that is recommended to guide the use of BRCA testing … Task Force on Genetic Testing (NIH). … of confirmatory testing.

43. Developing and Testing a Tool for the Classification of Study Designs in Systematic Reviews of Interventions and Exposures | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/study-design-classification/research
    November 01, 2017 - SHARE: Developing and Testing … Results In the first round of testing the inter-rater reliability was fair among the testers (? … The second round of testing showed improved interrater reliability (? … In both rounds of testing, the level of agreement for testers who had completed graduate-level training … Project Timeline Developing and Testing a Tool for the Classification of Study Designs in Systematic

44. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - for CYP2C19 variants and phenotypic testing for platelet reactivity, focusing on standardizing testing … This appears to be a very rigorous review of platelet function testing and CYP2C19 genetic testing for … We reviewed several studies comparing testing versus no-testing strategies for tests measuring platelet … Use of phenotypic testing (but not genetic testing) as a monitoring test can be considered a variation … Pharmacokinetic and pharmacodynamic testing (such as platelet function testing) in healthy volunteers

45. Topic 0451 Celiac Disease NSD FINAL (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
    January 01, 2013 - Testing … The current strategy for diagnosing CD involves serial serologic and histopathologic testing. … After initial evaluation and testing for iron, folate and vitamin B12 deficiencies and ruling out other … Objective 4 - Expected consequences of testing for CD (Celiac 4) a. … What are the expected consequences of testing for CD in the following populations: i.

46. Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic Pain Treatments | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/machine-learning-tool/methods-report
    August 01, 2021 - Español EHC FAQs Home Evidence Reports Testing … Treatments SHARE: Testing … Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic Pain Treatments … Project Timeline Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic … created October 2020 Internet Citation: Research Report: Testing

47. Prognostic Tests (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Setting Who will use the prognostic test; how the test will be used; what the applicable testing scenario … Cost-effectiveness: Do the improvements in patient outcomes justify the additional costs of testing and … Were the subjects somehow referred or selected for testing? What was the testing scenario? … The second question asks about the subject selection and testing scenario. … Subpart A asks about uniformity of testing across all sites or all studies being reported.

48. Prognostic Tests (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Setting Who will use the prognostic test; how the test will be used; what the applicable testing scenario … Cost-effectiveness: Do the improvements in patient outcomes justify the additional costs of testing and … Were the subjects somehow referred or selected for testing? What was the testing scenario? … The second question asks about the subject selection and testing scenario. … Subpart A asks about uniformity of testing across all sites or all studies being reported.

49. Disposition of Comments for Comparative Effectiveness Review 130 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preoperative-testing_disposition-comments.pdf
    January 29, 2014 - vs non-testing. … versus not testing (or other protocols for testing). … routine or per protocol vs. ad hoc testing. … One of the key issues of preoperative testing is that more testing may be required in places less able … The study evaluates all preoperative testing.

50. Considering the Range of Decision-Relevant Effects (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
    June 01, 2012 - Determine the group to which the testing outcomes are most relevant. … consideration; and (5) the costs of testing. … Additional patient outcomes and pathways in evaluations of testing. … consideration; and (5) the costs of testing. … Genetic Testing Segal JB.

51. Considering the Range of Decision-Relevant Effects (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
    June 01, 2012 - Determine the group to which the testing outcomes are most relevant. … consideration; and (5) the costs of testing. … Additional patient outcomes and pathways in evaluations of testing. … consideration; and (5) the costs of testing. … Genetic Testing Segal JB.

52. Antibiotics-Respiratory-Infection Clinician (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_clinician.pdf
    March 01, 2016 - While procalcitonin point-of-care testing reduced antibiotic prescribing in adults, use of an adult … Clinical Interventions (Point-of-Care Testing): ��Procalcitonin point-of-care testing in adults reduced … ��Streptococcal antigen point-of-care testing (rapid strep testing) reduced overall prescribing by 20 … ��Point-of-care testing for influenza in children had no effect on antibiotic prescribing (���). … strep testing 3 RCTs ��� Inappropriate prescribing -33% Greater reduction with rapid strep testing 1

53. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-test/research
    December 01, 2019 - EHC FAQs Home Evidence Reports PCA3 Testing … SHARE: PCA3 Testing … Comparative effectiveness review: prostate cancer antigen 3 (PCA3) testing for the diagnosis and management … Project Timeline PCA3 Testing for the Diagnosis and Management of Prostate Cancer May 4, 2011 … November 2017 Internet Citation: Systematic Review: PCA3 Testing

54. Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
    March 29, 2016 - Peer Reviewer 1 Methods However it would be helpful to include testing vs no testing in low risk groups … We identified no studies evaluating testing versus no testing that met our inclusion criteria. … testing as analyzed in this report. … There were no studies identified that evaluated testing versus no testing in the population of interest … No studies comparing testing vs. no testing were identified.

55. Effective Health Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0068_01-30-2009.pdf
    January 01, 2009 - Results of Topic Selection Process & Next Steps  Antinuclear autoantibody and rheumatoid factor testing … is interested in the diagnostic accuracy of antinuclear antibody (ANA) and rheumatoid factor (RF) testing … clinical factors that may modify accuracy or benefits and harms associated with obtaining ANA and RF testing … not limited to):  Patient referrals (i.e., to pediatric rheumatologists)  Additional diagnostic testing … (e.g., radiologic studies, laboratory testing, etc

56. Quantitative Synthesis: Chapter 4. Quantifying, Testing, and Exploring Statistical Heterogeneity (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-4.pdf
    July 01, 2019 - Quantifying, Testing, and Exploring Statistical Heterogeneity Quantitative Synthesis Chapter 4. … Quantifying, Testing, and Exploring Statistical Heterogeneity Prepared for: The Agency for Healthcare … incorporate the subgroup factor into a meta-regression framework.20 − This enables formal statistical testing … , allows for quantification of heterogeneity and testing for residual heterogeneity. 20. … Quantifying, Testing, and Exploring �Statistical Heterogeneity Learning objective Statistical heterogeneity

57. Gene Expression Profiling for Predicting Outcomes in Patients With Stage II Colon Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/colon-cancer-gene-profiling/research-protocol
    December 01, 2019 - What are the potential benefits and harms of this testing compared to current practice? … Is GEP testing a replacement or add-on technology? … Are there additional specific features of this testing (technology) that need to be considered? … Question 4 What important issues are raised by using GEP testing for stage II colon cancer? … Genomic Testing: ACCE Model Process for Evaluating Genetic Tests.

58. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
    May 18, 2011 - Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Fecal DNA Testing … (FOBT) or fecal immunohistochemical testing (FIT) annually; and flexible sigmoidoscopy every 5 years … . 3 Fecal DNA testing detects molecular alterations associated with CRC development in cellular … Question 6: Harms What are the potential harms of fecal DNA testing? … FOBT = Fecal Occult-Blood Testing USPSTF = U.S.

59. Chapter 10: Deciding Whether To Complement a Systematic Review of Medical Tests With Decision Modeling | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-decision-models/methods
    December 01, 2019 - The links between testing, test results, and patient outcomes are typically complex: even when testing … In most cases of evaluating medical testing, some type of formal modeling will be useful. … Table 10–2 classifies the results of PET testing. Table 10–2. … Patients without suggestive clinical examination are not candidates for PET testing. … Additional patient outcomes and pathways in evaluations of testing.

60. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-antigen-3-gene/research
    December 01, 2019 - EHC FAQs Home Evidence Reports PCA3 Testing … SHARE: PCA3 Testing … Project Timeline PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs … November 2017 Internet Citation: Systematic Review: PCA3 Testing